Latest news

ROCKVILLE, Md. , May 8, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting, taking place in New Orleans , May 13 through 17, 2025 . The presentations highlight REGENXBIO's leading end-to-end

ROCKVILLE, Md. , May 6, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences: BofA Securities Health Care Conference 2025 Presentation:  Tuesday, May 13, 2025 at 5:00 p.m. PT Location:  Las Vegas, NV RBC Global Healthcare

ROCKVILLE, Md. , April 30, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Monday, May 12 , at 4:30 p.m. ET to discuss its financial results for the first quarter ended March 31, 2025 , and recent operational highlights.

Aravindhan Veerapandiyan, M.D., Arkansas Children's Hospital

Carolina Tesi-Rocha M.D., Stanford Children's Hospital

Steven Foltz, Ph.D., REGENXBIO